We are happy to annouce the publication of the manuscript "Single Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases" by Thomas Charlon, published in August in PLOS ONE.
The article describes a clustering methodology aimed at removing the ancenstry bias in genetic analyses and uncovering disease-relevant traits. The project was conducted as part of the PRECISESADS consortium which is developping a new, biomarker-based, classification for inflammatory auto-immune disease.
Karl Forner and Claudia Armenise have participated at the Topcoder data science challenge. The event was sponsored by the Broad institute and Harvard university. The challenge consisted in finding ways of optimizing the alignment of multiple DNA sequences to a reference DNA, taking into account small differences, “errors”, in the sequences.
Quartz Bio has moved to the Geneva Campus Biotech. “Moving to your own offices is an important step in the life of a start-up”, says J. Wojcik CEO of Quartz Bio. “The FONGIT incubator has played an essential role in helping our company grow during the last three years”. The new offices will provide space to welcome our new collaborators in an innovation-driven environment aimed towards personalized medicine and digital health.
Quartz Bio will be sponsoring for the third time the Oxford Global Annual Biomarkers Congress (25th - 26th February - Manchester, UK). Come and meet us at our stand.